References
- Allen, P., Kaplan, M. D., Kusumam, J. and Michael, S.,Pathways for bradykinin formation and inflammatory disease. J. AIlerg. Clin. Immun., 109(2), 195-209 (2002) https://doi.org/10.1067/mai.2002.121316
- Alving, B. M., Hojima, Y., Pisano, J. J., Mason, B. L., Buckingham, R. E., Mozen, M. M. and Finlayson, J. S., Hypotension associated with prekallikrein activator (Hageman-factor fragments) plasma protein fraction. N. Engl. J. Med., 229, 66-70 (1978)
- Alving, B. M., Tankersley, D. L., Mason, B. L., Rossi, F., Aronson, D. L. and Finlayson, J. S., Contact-activated factors: contaminants of immunoglobulin preparations with coagulant and vasoactive properties. J. Lab. Clin. Med., 96, 334-346 (1980)
- Bagdasarian, A., Talamo R. C., and Colman, R. W., Simple assay for prekallikrein activators. Immunol. Commun., 2(1), 93-103 (1973) https://doi.org/10.3109/08820137309022885
- Council of Europe. European Pharmacopoeia, 3rd edition; p. 95, (1997)
- Domenico, R., Anna, R., and Girolamo, C., Pharmacology of the kallikrein-kinin system. Pharmacol. Res., 35(6), 513-515 (1997) https://doi.org/10.1006/phrs.1997.0178
- Friberger, P., Gnos, M., Gustavsson, S., Laurell, L. and Claeson, G., A new specific substrate for the determination of plasmin activity. In Scully, M. F. and Kakkar, V. V. (Eds.): Chromogenic peptide substrates: chemistry and clinical usage. Churchill Livingstone, Edinburgh London and New York, pp. 121-127,(1978)
- Griffin, J. H., Role of surface in surface-dependent activation of Hageman factor(blood coagulation factor XII). Proc. Natl. Acad. Sci., 75(4), 1998-2002 (1978) https://doi.org/10.1073/pnas.75.4.1998
- Hannele T. and Suomela. H., An optimized assay for prekallikrein activator activity in human plasma products. Thromb. Res., 27(1), 35-44 (1982) https://doi.org/10.1016/0049-3848(82)90275-4
- Heinonen, J., Peltola, K., Himberg, J. J. and Suomela, H., Vasodilator effect of plasma protein fraction correlates with prekallikrein activator activity. Ann. Thorac. Surg., 33(3), 244-249 (1982) https://doi.org/10.1016/S0003-4975(10)61919-4
- Heinonen, J., Peltola, K., Himberg, J.J., and Suomela, H., Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF). Develop. Biol. Standard, 48, 129-130 (1981)
- Judith, C., Annie, M., Shen, Y. and Andrew, H., Kallikreins and kinins in inflammatory-like events in the reproductive tract. Pharmacol. Res., 35(6), 537-540 (1997) https://doi.org/10.1006/phrs.1997.0183
- Kaplan, A. P. and Austen, K. F., A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J. Exp. Med., 133(4), 696-712 (1971) https://doi.org/10.1084/jem.133.4.696
- Kaplan, A. P., and Austen, K. F., A pre-albumin activator of prekallikrein. J. Immunol., 105(4), 802-811 (1970)
- Kaplan, A. P., Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Prog. Hemost. Thromb., 4, 127-75 (1978)
- Kaplan, A. P., Kay, A. B. and Austen, K. F., A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J. Exp. Med., 135(1), 81-97 (1972) https://doi.org/10.1084/jem.135.1.81
- Kerry, P. J., Curtis, A. D., Catherine, J., and Thomas, D. P., Standardization of prekallikrein activator (PKA): the 1st British Reference Preparation for PKA. British J. Haematol., 52, 275-281 (1982) https://doi.org/10.1111/j.1365-2141.1982.tb03890.x
- Kuwahara, S. S., Prekallikrein activator (Hageman factor fragment) in human plasma fraction. Transfusion, 20, 433-439 (1980) https://doi.org/10.1046/j.1537-2995.1980.20480260275.x
- Luben, G., Quast, U. and Geiger, H., Prekallikrein activator levels and side effects with human albumin preparations. Develop. Biol. Standard, 48, 123-127 (1981)
- Lundbland, J. L., In vitro assay for prekallikrein activator (PKA). Develop. Biol. Standard, 44, 107-114 (1979)
- Mandle, R. J., Colman, R. W., and Kaplan, A. P., Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci., 73(11), 4179-4183 (1976) https://doi.org/10.1073/pnas.73.11.4179
- Marley, P. B. and Gilbo, C. M., Temperature sensitivity within the pasteurization temperature range of prekallikrein activator in stable plasma protein solution (SPPS). Transfusion, 21, 320-324 (1981) https://doi.org/10.1046/j.1537-2995.1981.21381201805.x
- McMillin, C. R., Saito, H, Ratnoff, O. D., and Walton, A. G., The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents. J. Clin. Invest., 54(6), 1312-1322 (1974) https://doi.org/10.1172/JCI107877
- Radcliffe, R. Nemerson, Y. and Emerson, Y., Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J. Biol. Chem., 251(16), 4749-802 (1976)
- Revak, S. D., Cochrane, C. G., and Griffin, J. H., The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. J. Clin. Invest., 59(6), 1167-75 (1977) https://doi.org/10.1172/JCI108741
- Revak, S. D., Cochrane, C. G., Johnston, A. R. and Hugli, T. E., Structural changes accompanying enzymatic activation of human Hageman factor. J. Clin. Invest., 54(3), 619-27 (1974) https://doi.org/10.1172/JCI107799
- Rob, F., Van, R., Joa, C. B., Donald, M. S., Johan, D. and Jan. A. V. M., Bradykinin-mediated hypotension after infusion of plasma-protein fraction. J. Lab. Clin. Med., 100, 288-295 (1982)
- Siv, F., Nils-Ove, H., Halvard G. and Kjell, B., Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy. Thrombosis Research, 93, 161-170 (1999) https://doi.org/10.1016/S0049-3848(98)00183-2
- Snape, T. J., Griffith, D., Vallet, L. and Wesley, E. D., The assay of prekallikrein activator in human blood products. Develop. Biol. Standard, 44,115-120 (1979)
- Tankersley, D. L., Fournel, M. A. and Schroeder, D. D., Kinetics of activation of prekallikrein by prekallikrein activator. Biochemistry, 19, 3121-3127 (1980) https://doi.org/10.1021/bi00555a001
- Turner, P. J., Young, I. F., Marley, P. B., Herrington, R. W. and Schiff, P., Albumin solutions- Their production and quality control. Develop. Biol. Standard, 67, 119-127 (1987)
- World Health Organization Technical Report Series. Control of albumin and plasma protein fraction. No. 840, Annex 2, Part B. 14. pp. 80-85 (1994)
- Yasda, J., Ueno, G., Kuratsuka, K., Homma, R., Hara, S., Kazama, M. and Ito, H., Japanese minimum requirements for albumin preparations: recent amendments and current problems. Develop. Biol. Standard., 48, 143-152 (1981)